For many years, astrocytes were primarily thought to function as supportive and structural elements in the brain. However, recent studies have revealed that they play much more complex and significant roles in the central nervous system (CNS) including the clearance of cellular debris, unwanted synapses and protein aggregates. Aggregated proteins are a common feature in many neurodegenerative diseases (NDs), including Alzheimer’s disease (AD). The pathology of AD is characterized by the formation of amyloid-beta plaques and the accumulation of Tau protein in neuronal cells. These protein aggregates are toxic to neurons and are released into the extracellular space, where they can be taken up by glial cells, such as astrocytes. The discovery of aggregated neuronal proteins within astrocytes has raised new questions about the mechanisms through which astrocytes operate this clearance. A novel mediator of this process, Annexin A2 (AnxA2), has been identified. AnxA2 is an actin-binding protein involved in processes such as endocytosis, exocytosis, and actin remodeling, which can interact directly with the N-terminal region of Tau. The aim of this study is to evaluate the role of AnxA2 in Tau clearance in astrocytes, shedding light on the mechanisms involved in this process and the degradation capacity of astrocytes.

For many years, astrocytes were primarily thought to function as supportive and structural elements in the brain. However, recent studies have revealed that they play much more complex and significant roles in the central nervous system (CNS) including the clearance of cellular debris, unwanted synapses and protein aggregates. Aggregated proteins are a common feature in many neurodegenerative diseases (NDs), including Alzheimer’s disease (AD). The pathology of AD is characterized by the formation of amyloid-beta plaques and the accumulation of Tau protein in neuronal cells. These protein aggregates are toxic to neurons and are released into the extracellular space, where they can be taken up by glial cells, such as astrocytes. The discovery of aggregated neuronal proteins within astrocytes has raised new questions about the mechanisms through which astrocytes operate this clearance. A novel mediator of this process, Annexin A2 (AnxA2), has been identified. AnxA2 is an actin-binding protein involved in processes such as endocytosis, exocytosis, and actin remodeling, which can interact directly with the N-terminal region of Tau. The aim of this study is to evaluate the role of AnxA2 in Tau clearance in astrocytes, shedding light on the mechanisms involved in this process and the degradation capacity of astrocytes.

Investigating the Role of Annexin A2 in Astrocyte-Mediated Clearance of Tau Aggregates

ZANON, ILARIA
2023/2024

Abstract

For many years, astrocytes were primarily thought to function as supportive and structural elements in the brain. However, recent studies have revealed that they play much more complex and significant roles in the central nervous system (CNS) including the clearance of cellular debris, unwanted synapses and protein aggregates. Aggregated proteins are a common feature in many neurodegenerative diseases (NDs), including Alzheimer’s disease (AD). The pathology of AD is characterized by the formation of amyloid-beta plaques and the accumulation of Tau protein in neuronal cells. These protein aggregates are toxic to neurons and are released into the extracellular space, where they can be taken up by glial cells, such as astrocytes. The discovery of aggregated neuronal proteins within astrocytes has raised new questions about the mechanisms through which astrocytes operate this clearance. A novel mediator of this process, Annexin A2 (AnxA2), has been identified. AnxA2 is an actin-binding protein involved in processes such as endocytosis, exocytosis, and actin remodeling, which can interact directly with the N-terminal region of Tau. The aim of this study is to evaluate the role of AnxA2 in Tau clearance in astrocytes, shedding light on the mechanisms involved in this process and the degradation capacity of astrocytes.
2023
Investigating the Role of Annexin A2 in Astrocyte-Mediated Clearance of Tau Aggregates
For many years, astrocytes were primarily thought to function as supportive and structural elements in the brain. However, recent studies have revealed that they play much more complex and significant roles in the central nervous system (CNS) including the clearance of cellular debris, unwanted synapses and protein aggregates. Aggregated proteins are a common feature in many neurodegenerative diseases (NDs), including Alzheimer’s disease (AD). The pathology of AD is characterized by the formation of amyloid-beta plaques and the accumulation of Tau protein in neuronal cells. These protein aggregates are toxic to neurons and are released into the extracellular space, where they can be taken up by glial cells, such as astrocytes. The discovery of aggregated neuronal proteins within astrocytes has raised new questions about the mechanisms through which astrocytes operate this clearance. A novel mediator of this process, Annexin A2 (AnxA2), has been identified. AnxA2 is an actin-binding protein involved in processes such as endocytosis, exocytosis, and actin remodeling, which can interact directly with the N-terminal region of Tau. The aim of this study is to evaluate the role of AnxA2 in Tau clearance in astrocytes, shedding light on the mechanisms involved in this process and the degradation capacity of astrocytes.
Astrocytes
Clearance
Tau protein
File in questo prodotto:
File Dimensione Formato  
Zanon_Ilaria.pdf

accesso riservato

Dimensione 2.88 MB
Formato Adobe PDF
2.88 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/81083